These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 5351088)
1. [Dhnmics of histological changes in the bone marrow in a patient with multiple myeloma during the process of treatment with sarcolysin]. Voronin VM; Rybakova ME Probl Gematol Pereliv Krovi; 1969 Feb; 14(2):53-6. PubMed ID: 5351088 [No Abstract] [Full Text] [Related]
2. Breast cancer and acute leukemia in a patient with multiple myeloma treated with melphalan. Meytes D; Katz DR Isr J Med Sci; 1973 Aug; 9(8):1044-7. PubMed ID: 4753846 [No Abstract] [Full Text] [Related]
3. [Erythroleukemia in multiple myeloma. A case report]. Streuli R; Voellmy W Schweiz Med Wochenschr; 1987 Feb; 117(8):286-91. PubMed ID: 3470922 [TBL] [Abstract][Full Text] [Related]
4. [Refractory anemia with partial myeloblastosis in multiple myeloma treated with melphalan]. Morlock G; Bataille R; Sany J; Serre H Sem Hop; 1977 Apr 9-16; 53(14-15):853-6. PubMed ID: 194338 [No Abstract] [Full Text] [Related]
5. [Cytogenetical and clinico-hematological changes in myeloma disease]. Dubrova SE; Dygin VP; Ushakova EA Tsitologiia; 1966; 8(2):241-9. PubMed ID: 5984072 [No Abstract] [Full Text] [Related]
6. [On the nature of bone regeneration processes in patients with multiple myeloma treated with sarcolysin]. Tager IL; Merkulova NV; Tseshkovskiĭ MS Vestn Rentgenol Radiol; 1965; 40(2):13-7. PubMed ID: 5853760 [No Abstract] [Full Text] [Related]
7. Non-secretary multiple myeloma in a young Ethiopian: case report. Teklesilassie H; Sherif A; Diro E Ethiop Med J; 2010 Apr; 48(2):165-8. PubMed ID: 20608020 [TBL] [Abstract][Full Text] [Related]
8. [Myeloma, melphalan and acute myelo-monocytic leukemia. Apropos of a case]. Cywiner-Golenzer C; Adotti F; Marsan C; Quillard A; Henon P; Grimaldi A; Dryll A Sem Hop; 1974 Jan; 50(3):207-11. PubMed ID: 4367926 [No Abstract] [Full Text] [Related]
9. Multiple myeloma and acute myelomonocytic leukemia. Kyle RA; Pierre RV; Bayrd ED N Engl J Med; 1970 Nov; 283(21):1121-5. PubMed ID: 5273282 [No Abstract] [Full Text] [Related]
11. [The prognostic significance of cytological study of the bone marrow in multiple myeloma]. Iakovleva SV Ter Arkh; 2000; 72(7):48-51. PubMed ID: 10983321 [TBL] [Abstract][Full Text] [Related]
13. [Myeloma with extramedullary extension coinciding with the normalization of serum paraproteins after treatment]. Bernat S; Gozalbo T; García-Boyero R; Guinot M Sangre (Barc); 1998 Feb; 43(1):96-7. PubMed ID: 9577192 [No Abstract] [Full Text] [Related]
14. Bone marrow changes following chemotherapy for multiple myeloma--a clinicopathological study of biopsy cases. Kurihara K; Hill W; Burkhardt R; Kettner G; Hashimoto N Nihon Ketsueki Gakkai Zasshi; 1987 Jul; 50(4):876-89. PubMed ID: 3687331 [No Abstract] [Full Text] [Related]
15. The additional role of bone marrow particle sections ('clot sections') in confirming marrow involvement by multiple myeloma: a single centre study. Mathur K; Soutar R Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e179-80. PubMed ID: 19196378 [No Abstract] [Full Text] [Related]
16. [Cell types in multiple myeloma: analysis of the correlation of bone marrow aspirates and biopsies according to 2 classifications]. de la Rosa Alcaide MA; Hernández Nieto L; Hernández García MT; Brito Barroso ML Sangre (Barc); 1989 Aug; 34(4):313-4. PubMed ID: 2772787 [No Abstract] [Full Text] [Related]
17. Multiple myeloma first observed as multiple cutaneous plasmacytomas. Shah A; Klimo P; Worth A Arch Dermatol; 1982 Nov; 118(11):922-4. PubMed ID: 6814367 [TBL] [Abstract][Full Text] [Related]